VYOME HOLDINGS, INC. Accumulated Other Comprehensive Income
VYOME HOLDINGS, INC. (HIND) had Accumulated Other Comprehensive Income of -$119.88 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$119.88K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$118.32K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$78.86K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$68.36K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$119.88K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$118.32K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$78.86K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$68.36K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$53.16K 8-K · filed 2025-09-02 | -$109.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$110.00K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | -$53.17K 10-K · filed 2026-03-18 | -$104.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | -$88.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$89.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$96.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$88.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | -$94.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$95.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | -$93.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$88.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | -$68.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$72.00K 10-Q · filed 2022-08-19 | |
| 2021-12-31 | -$92.00K 10-K · filed 2023-04-17 | |
| 2021-09-30 | -$107.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$109.00K 10-Q · filed 2021-08-16 | |
| 2020-12-31 | -$121.00K 10-K · filed 2022-04-08 | |
| 2018-12-31 | $0.00 10-K · filed 2019-02-22 | |
| 2018-09-30 | -$2.00K 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $1.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | -$5.00K 10-K · filed 2019-02-22 | |
| 2017-09-30 | -$4.00K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | -$19.00K 10-Q · filed 2017-08-02 | |
| 2017-03-31 | -$19.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$1.00K 10-K · filed 2018-03-05 | |
| 2016-09-30 | $5.00K 10-Q · filed 2016-11-10 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |